| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/2011 | CA2784118A1 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 07/14/2011 | CA2782568A1 Use of cry1ab in combination with cry1be for management of resistant insects |
| 07/14/2011 | CA2782565A1 Use of cry1da in combination with cry1be for management of resistant insects |
| 07/14/2011 | CA2782557A1 Use of cry1da in combination with cry1ca for management of resistant insects |
| 07/14/2011 | CA2782552A1 Combined use of cry1fa and cry1ab proteins for control of cry-resistant sugarcane borer and for insect resistance management in sugarcane |
| 07/14/2011 | CA2782549A1 Combined use of cry1ca and cry1ab proteins for insect resistance management |
| 07/14/2011 | CA2782366A1 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1 |
| 07/13/2011 | EP2343554A1 Biomarker for microdomain disorder |
| 07/13/2011 | EP2343380A1 Immunoglobulin variable region cassette exchange |
| 07/13/2011 | EP2343378A1 Production of high mannose proteins in plant culture |
| 07/13/2011 | EP2343377A2 Proteins associated with abiotic stress response and homologs |
| 07/13/2011 | EP2343376A2 Proteins associated with abiotic stress response and homologs |
| 07/13/2011 | EP2343375A2 Proteins associated with abiotic stress response and homologs |
| 07/13/2011 | EP2343374A1 Molecules of HDV nucleic acids, fragments and applications thereof |
| 07/13/2011 | EP2343373A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 07/13/2011 | EP2343372A1 Method for predicting pharmacological efficacy of anti-tnf antibody preparation on rheumatoid arthritis, and pharmacological efficacy prediction apparatus |
| 07/13/2011 | EP2343369A1 Laglidadg homing endonuclease variants having mutations in two functional subdominants und use thereof |
| 07/13/2011 | EP2343368A1 Laglidadg homing endonuclease variants having mutations in two functional subdominants und use thereof |
| 07/13/2011 | EP2343367A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343366A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343365A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343364A2 Tubulin regulatory elements for use in plants |
| 07/13/2011 | EP2343318A2 Antibodies binding to a C-terminal fragment of Apolipoprotein E |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343315A2 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 07/13/2011 | EP2343312A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2342970A2 Barley with reduced SSII activity and starch and starch containing products with a reduced amylopectin content |
| 07/13/2011 | EP2342567A1 Identification and characterisation of recombinant viral gene therapy vectors |
| 07/13/2011 | EP2342562A1 Improved method of rna display |
| 07/13/2011 | EP2342361A2 Genetic markers for assessing risk of developing bipolar disorder |
| 07/13/2011 | EP2342345A1 Production of ngf in plant |
| 07/13/2011 | EP2342344A1 System for capturing&modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 07/13/2011 | EP2342343A2 Nuclear receptor sensor system in transgenic animal |
| 07/13/2011 | EP2342342A2 Oligonucleotidic sequences able to silence the expression of the cyclin d1 -trop2 chimera and uses thereof in medical field |
| 07/13/2011 | EP2342341A1 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
| 07/13/2011 | EP2342340A1 Rna interference in skin indications |
| 07/13/2011 | EP2342339A2 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 07/13/2011 | EP2342337A1 Method for diagnostic marker development |
| 07/13/2011 | EP2342336A2 Continuous directed evolution of proteins and nucleic acids |
| 07/13/2011 | EP2342335A1 Novel gene cluster |
| 07/13/2011 | EP2342334A1 Tumor vascular marker-targeted vaccines |
| 07/13/2011 | EP2342332A1 Impedance spectroscopy measurement of dna |
| 07/13/2011 | EP2342331A2 Herbicide-resistant ahas-mutants and methods of use |
| 07/13/2011 | EP2342329A1 Beta-glucosidase variants having improved activity, and uses thereof |
| 07/13/2011 | EP2342322A1 Method for producing eukaryotic organisms with enhanced pathogen resistance and/or resistance to stress and eukaryotic transgenic organisms with enhanced pathogen resistance and/or resistance to stress |
| 07/13/2011 | EP2342320A1 Chinese hamster ovary cell lines |
| 07/13/2011 | EP2342230A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 07/13/2011 | EP2342224A2 Novel vectors for production of interferon |
| 07/13/2011 | EP2342223A2 Modified animal erythropoietin polypeptides and their uses |
| 07/13/2011 | EP2342218A1 Transgenic plants with increased yield |
| 07/13/2011 | EP2342217A2 Novel shigella frotein antigens and methods |
| 07/13/2011 | EP2342213A1 Antimicrobial peptides |
| 07/13/2011 | EP2341943A2 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications |
| 07/13/2011 | EP2341937A1 Composition for treating disease |
| 07/13/2011 | EP2341924A2 Methods of treating hepatitis c virus infection |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP2121935B1 Transcriptional repressors of cytokinin signaling and their use |
| 07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 07/13/2011 | EP2019864B1 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| 07/13/2011 | EP1989939B1 Method using an oasis gene-deficient mouse |
| 07/13/2011 | EP1948794B1 A method for in vitro molecular evolution of protein function |
| 07/13/2011 | EP1904626B1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 07/13/2011 | EP1860185B1 Screening method |
| 07/13/2011 | EP1828247B1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 07/13/2011 | EP1718739B1 Methods of refolding mammalian glycosyltransferases |
| 07/13/2011 | EP1718663B1 Chimeric promoters for use in plants |
| 07/13/2011 | EP1649017B1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 07/13/2011 | EP1647593B1 Method for producing l-histidine using bacteria of the enterobacteriaceae family |
| 07/13/2011 | EP1601775B1 Rodent model for the fast identification of pharmaceutical active compounds in vivo |
| 07/13/2011 | EP1543158B1 Regulated aptamer therapeutics |
| 07/13/2011 | EP1465990B1 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/13/2011 | EP1442140B1 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 07/13/2011 | EP1367886B1 Scce transgenic mice and their use as models of human disease |
| 07/13/2011 | EP1334199B1 A transformation system in camelina sativa |
| 07/13/2011 | EP1305430B1 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1274986B1 Device and method for determining multiple analytes |
| 07/13/2011 | EP1269187B1 Function homology screening |
| 07/13/2011 | EP1190043B1 Glycoprotein vi and uses thereof |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN102124121A Production of cellulase enzymes in plant hosts using transient agroinfiltration |
| 07/13/2011 | CN102124115A Virus purification |
| 07/13/2011 | CN102124114A Method to obtain transgenic plants resistant to phytopathogen attack based on RNA interference (RNAi) |
| 07/13/2011 | CN102124113A Plant promoters of the XVSAP1 gene |
| 07/13/2011 | CN102124112A Homologous recombination-based DNA cloning methods and compositions |
| 07/13/2011 | CN102124111A Novel genes involved in biosynthesis |
| 07/13/2011 | CN102124110A Transcriptional and post-transcription regulation of transcription factor for drought resistance |
| 07/13/2011 | CN102124109A Gene of porcine alpha-S1 casein, a promoter of the same and use thereof |
| 07/13/2011 | CN102124108A Use of EIF-5A1 SIRNA to protect islets cells from apoptosis and to preserve their functionality |
| 07/13/2011 | CN102124107A RNA interference mediated inhibition of proprotein convertase subtilisin Kexin 9 (PCSK9) gene expression using short interfering nucleic acid (siNA) |
| 07/13/2011 | CN102124106A Method for production of cDNA library having reduced content of cDNA clone derived from highly expressed gene |
| 07/13/2011 | CN102124105A Antibody capable of binding specifically to Abeta-oligomer, and use thereof |
| 07/13/2011 | CN102124104A Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase |
| 07/13/2011 | CN102124103A Evaluation/screening method for diseases associated with D-amino acid utilizing Dao1-/-mouse |
| 07/13/2011 | CN102124030A Antibody against oxidized ldl/ss2gpi complex and use of the same |
| 07/13/2011 | CN102124025A Nematode-resistant transgenic plants |